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Abstract.
BACKGROUND: 10–30% of hospital stays by older patients are drug-related. The admission phase is important for
identifying drug-related problems, but taking an incorrect medication history often leads to medication errors.
OBJECTIVES: To enhance medication history recording and identify drug-related problems (DRPs) of older patients
admitted to emergency departments (EDs).
METHODS: DRPs were identified by pharmacists-led medication reconciliation and review procedures in two EDs in
Finland; Helsinki University Hospital (HUS), and Kuopio University Hospital (KUH). One-hundred-and-fifty patients aged
≥65-years, living at home and using ≥6 medicines were studied.
RESULTS: 100% of patients (N = 75) in HUS and 99% in KUH (N = 75), had discrepancies in their admission-medication
chart recorded by the nurse or physician. Associations between admission-diagnosis and drug-related problems were found in
12 patients (16%) in HUS and 22 patients (29%) in KUH. Of these, high-alert medications (e.g. antithrombotics, cytostatics,
opioids) were linked to eight patients (11%) in HUS and six patients (8%) in KUH. Other acute DRPs were identified in 19
patients (25%) in HUS and 54 patients (72%) in KUH. Furthermore, 67 patients (89%) in HUS and all patients in KUH had
non-acute DRPs.
CONCLUSIONS: Medication reconciliation and review at admission of older ED patients requires improvement in Finland.
Keywords: Emergency department, medication reconciliation, medication review, drug-related problems, older patients,
clinical pharmacy, high-alert medications, polypharmacy
1. Introduction
The majority of hospitalised patients are admitted via the emergency departments (EDs). The hectic
environment with short patient admission processing times, large patient volumes and growing numbers
of complicated and chronically ill patients without accurate medical history, make ED a critical point
from the medication safety perspective. Medication errors are common at the admission stage [1].
Estimated medication error rates vary from 4% to 14% [2, 3]. Even one third of prescribing errors that
occur in hospitals are a consequence of an incorrect medication history taken at the time of admission
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[4]. Thus, medication reconciliation should also be carried out at the admission of ED patients. It is
one of the key strategies to prevent adverse drug events and improve patient safety at all transitions
in care [5, 6]. A clinical pharmacist seems to obtain more comprehensive medication histories than
physicians [6].
Older ED patients (≥65 years) experience medication errors more often than do younger ED patients
because of complex medications and polypharmacy [7]. Age-related physiological, pharmacokinetic
and pharmacodynamic changes make older patients more vulnerable to the effects of the drugs [8]. In
addition, there are medications that pose a high risk for harmful effects and medication errors. These
high-risk or high-alert medications include medications with a narrow therapeutic index (NTI) [9–11].
Incident rates with these medications may not necessarily be higher than with other medications, but
when incidents do occur their impact on the patients are potentially more harmful [10, 11].
It is recommended that regular medication reviews are performed in order to manage polypharmacy
by identifying, resolving and preventing drug-related problems [12]. Different medication review
procedures are internationally used in both outpatient and inpatient settings [13–15]. A previous study
found that a pharmacist-led medication review for older ED patients with polypharmacy reduced
hospital admissions [16]. Older emergency patients are recommended to be systematically screened for
clinically relevant drug-related problems [17]. In the present study, the prospective screening procedure
for older ED patients was combined with the recording of medication history and with the medication
reconciliation and review. The recording of the medication history and medication reconciliation and
review were performed by clinical pharmacists in two EDs, which were compared and evaluated. The
aim of this study was, therefore, to demonstrate the need for enhancing the recording of medication
history at admission of elderly ED patients in Finland. The taking of medication history, medication
reconciliation and review had not been routine procedures at ED admission in Finland until this study.
2. Methods
2.1. Setting
The study was conducted from April 2014 to January 2015 in the respective emergency department
of two Finnish university hospitals. Two different EDs were chosen for comparing the feasibility
of the pharmacist-led medication reconciliation and medications review process in both settings. 1)
Helsinki University Hospital (HUS) provides specialized tertiary medical care, whereby 3000 hospital
beds serve a regional population of 1.6 million in the capital metropolitan area of Finland. The ED in
HUS has approximately 80 patient visits per day with internal, surgical and neurological specialities for
patients older than 16 years of age. Clinical pharmacy services are provided in the EDs, but the taking of
medication history including medication reconciliation and review have not been provided. 2) Kuopio
University Hospital (KUH) provides specialised medical care with 730 beds that serve over 840,000
residents in Eastern Finland. The ED of KUH usually has 200 patient visits per day and provides
tertiary, secondary and acute primary care. A clinical pharmacist the KUH-ED has been recording
medication history including medication reconciliations and reviews on a weekly basis since 2013.
2.2. Participants
The study was targeted at older ED patients with polypharmacy. The inclusion criteria were the
following: 1) ≥65 years old; 2) Finnish speaking; 3) home-dwelling; 4) oriented to time and place or
having a caring close relative who could be interviewed instead and 5) using ≥6 medications (including
over-the-counter medications, dietary supplements and herbal products) according to the admission
medication chart recorded by either the nurse or the physician in the ED. Two clinical pharmacists (one
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in HUS and the other in KUH), both of whom were accredited for conducting medication reviews,
worked from Monday to Friday 8am–6pm. They chose the first one or two patients who met the
inclusion criteria per day. All study participants (including caring close relatives who were interviewed)
gave their written informed consent before participation in the study.
2.3. Procedure for medication history recording including medication reconciliation and review
The prospective procedure applied in this study was designed not to interfere with normal ED
routines or passing-times. The starting point of the pharmacists-led medication reconciliation was
the admission medication chart taken by a nurse or a physician. In addition, clinical pharmacists
checked the possible referral medication chart and medication charts from previous hospital stays. The
information gathered from these charts were used to start the bed-side patient interview conducted at
ED. In some cases relatives or other care givers were also interviewed. The structured interview form
(see Additional File 1) was based on the clinical interview guide used in the Finnish Comprehensive
Medication Review procedure [18]. The content of DRP risk assessment tool, which is targeted at
nurses for the identification of the clinically most significant DRPs in older adults, was also reviewed
for content validation [19]. Medication reviews were conducted by the clinical pharmacists after
medication reconciliation. The pharmacists used a medication review form (see Additional File 2),
which had been modified from Comprehensive Medication Review procedure to be appropriate for the
emergency setting [18]. Pharmacists had full access to patients’ clinical and medical data, including
laboratory results (Type III clinical medication review according to Clyne’s typology) [20]. Special
attention was also paid to problems related to high-alert medications [10, 11] in order to identify the
ED’s high-alert medications at the admission stage.
2.4. Classification of drug-related problems in the mediation review procedure
The classification of the drug-related problems was done according to the medication review form
(see Additional File 2). The identified drug-related problems were divided in three groups as follows:
1) Drug-related problems linked to admission diagnoses. The root-cause relationship was judged by
comparing the patients’ symptoms and signs at admission (e.g. bleeding, constipation, dizziness)
to the established adverse drug reactions of used medications with possible impacts of clinically
problematic interactions and renal insufficiency.
2) The severe drug-related problems that were not related to admission diagnoses, but needed imme-
diate changes at ED (dose adjustment with renal insufficiency, adverse drug reactions) that were
categorised as acute.
3) The less severe drug-related problems (e.g. re-considering the need or efficacy of the medication,
need for monitoring) that could be resolved later after discharge and were determined to be non-
acute.
Before reporting the findings to the ED physicians, all reported cases were approved by the study
supervising physicians and they were considered to be clinically relevant. All clinically relevant findings
were reported to the ED physicians orally and were documented in the patient information system.
2.5. Data analyses
The used procedure in both EDs were assessed by the number of discrepancies and drug-related
problems that were identified by the clinical pharmacists. The data were analysed by using descriptive
statistics. We calculated 1) patients characteristics; 2) number and frequencies of discrepancies in
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admission medication charts that had been recorded for each patient by nurses or physicians and which
was subsequently compared with medication reconciliation procedure conducted by pharmacists; 3)
number and frequencies of clinically problematic drug-related problems (admission related, acute and
non-acute) and their subtypes according to the medication review form. The results from HUS and
KUH were analysed separately to find any possible differences in the feasibility of the procedure
performed in the ED of either a tertiary or secondary hospital.
3. Results
3.1. Patient characteristics
A total of 150 ED patients (75 of HUS and 75 of KUH) were included. The patient characteristics
are presented in Table 1. The patients in KUH were slightly older and used more medications than
those in HUS.
3.2. Accuracy of the medication charts
Every patient in HUS (n = 75) and all but one patient in KUH 99% (n = 74) had discrepancies in the
medication history as taken by the ED nurse or physician when compared to the pharmacists reconciled
medication chart. Nearly four-fifths, 79% of patients in HUS and 65% of patients in KUH had at least
one omission of long-term medication and the majorities of these (63% in HUS and 47% in KUH)
were related to prescription medications. Omissions of PRN (pro re nata, used as needed) medications
were even more common: 92% of patients in HUS and 91% of patients in KUH had these and they
were typically related to over-the-counter medications (72% in HUS and KUH). In HUS 33% and
in KUH 48% of patients had additional medications in the admission medication chart obtained by
normal process, which were not really in use.
Table 1
Patient characteristics (N = 150)
HUS (n = 75) KUH (n = 75)
Age, years (range)
mean (range) 76 (65−92) 79 (66−98)
Sex, n (%)
female 46 (61%) 42 (56%)
male 29 (39%) 33 (44%)
Specialty, n (%)
surgery 30 (40%)
internal medicine 27 (36%) NA∗
neurology 13 (17%)
pulmonary 5 (7%)
Number of used medications, n (range)
all medications 15 (6−23) 17 (8−27)
long-term medications 9 (4−20) 11 (6−23)
PRN medications∗∗ 4 (0−11) 5 (1−14)
medications prescribed in the ED 2 (0−8) 1 (0−4)
∗secondary/primary care ED: patients are arriving without a referral and meet
general physician first; ∗∗pro re nata = as needed.
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Table 2
Clinically harmful drug-related problems (DRPs, HUS: n = 316; KUH: n = 446) obtained from medication reviews of 150
patients
HUS KUH





n = 12 (16%) n = 30 (9%) 2.5 n = 22 (29%) n = 43 (9%) 2.0
Acute drug-related
problems
n = 19 (25%) n = 50 (16%) 2.6 n = 54 (72%) n = 111 (25%) 2.1
Drug-related,
non-acute problems
n = 67 (89%) n = 236 (75%) 3.5 n = 75 (100%) n = 293 (66%) 3.9
No drug-related
problems
n = 6 (8%) n = 0 (0%)
3.3. Drug-related problems associated to admission diagnoses
As many as 92% (n = 69/75) of patients in HUS and 100% of patients in KUH had clinically relevant
drug-related problems (Table 2). Drug-related problems were associated to admission diagnoses of
12 patients (16%) in HUS and 22 patients (29%) in KUH (Table 3). There were 30 (2.5 per patient)
patients in HUS and 43 (2.0 per patient) in KUH for drug-related problems associated to admission
diagnoses and the majority of these were adverse drug reactions or clinically problematic interactions
(Figs. 1 and 2).
The US Institute for Safe Medication Practices (ISMP) has a list of high-alert medications [10, 11]
some of which contributed to the admission of eight patients (11%) in HUS and six patients (8%) in
KUH (Table 3). These medications included antithrombotics, opioids, oral hypoglycaemic agents and
cytostatics. Antithrombotics were related to bleedings in seven patients. Cytostatics were related to
infections and fever for two patients. Empirically established adverse drug reactions of opioids such
as constipation and bile duct spasm were related to admission diagnoses of four patients. Ineffective
medications (ineffective treatment or dose) were related to two admissions and this was linked to
ineffective opioids and oral hypoglycaemic agents. In addition to the high-alert medications, other
medications were related to diagnoses of four patients (5%) in the HUS group and 15 patients (10%) in
the KUH group (Table 4). Antihypertensives and diuretics were usually related to a weakened general
condition, dizziness, collapses and falls. Anticholinergic agents and benzodiazepines were related to
falls, whereas antibiotics were related to diarrhoea.
3.4. Other acute drug-related problems requiring action in the ED
There were 19 patients (25%) in HUS that presented with 50 acute drug-related problems (2.6 per
patient, Table 2) that required action in the ED. The majority of these problems were related to the
taking of an inappropriate dose or medication by a patient with renal insufficiency (32%) followed by
clinically problematic interactions (16%), re-considering the need or efficacy of the medications (12%)
and adverse drug reactions (10%, Fig. 1). A typical patient in the HUS group had renal insufficiency
with several inappropriate medications or doses (NSAIDs, ACE-inhibitors, statins, ASA, codeine,
cefuroxime, metformin, digoxin, methotrexate or radio contrast media). Other common suggestions
that were made were recommendations for using proton pump inhibitors and paracetamol instead of
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Table 3
Admission diagnoses (HUS: n = 8, KUH: n = 6) associated with high-alert medications [10, 11]∗
Unit Admission diagnoses Medications High-Alert Medication
Group
HUS dyspnoea, anaemia rivaroxaban∗ +
fluvoxamine
Antithrombotics
HUS anaemia, melena warfarin∗ + ASA∗ Antithrombotics













HUS infection, fever seizure hydroxyurea∗ Cytostatics





HUS bile duct spasms paracetamol + codeine∗ Opioids


















ASA∗ + sitalopram +
tramadol∗ + metamizole
Antithrombotics, Opioids
KUH fever hydroxyurea∗ Cytostatics
KUH leg pain worsening paracetamol + codeine∗
(ineffective)
Opioids
KUH intestinal obstruction paracetamol + codeine∗ +
atenolol + atorvastatin
Opioids
ASA = acetylsalicylic acid.
ibuprofen for analgesia to patients at risk of bleeding. There were 54 patients (72%) in KUH group
whom had presented with 111 acute drug-related problems (2.1 per patient, Table 2), which were
usually related to adverse drug reactions (24%), clinically problematic interactions (15%), change
of administration schedule or route (15%) or starting new medications (11%, Fig. 2). Typical acute
findings in KUH were related to adverse drug reactions which were treated with new medications.
3.5. Drug-related, non-acute problems
Two-thirds of patients 67 (89%) in HUS had drug-related, non-acute problems that needed action
after discharge (Table 2). There were 236 drug-related problems (3.5 per patient), which were pre-
dominantly related to the re-consideration of the need or efficacy of the currently used medication
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Fig. 1. The clinically relevant drug-related problems (DRPs, n = 316) obtained from 75 medication reviews in HUS.
∗Monitoring: therapeutic drug monitoring (n = 9), checking laboratory results (n = 7), bone mass measurement (n = 4),
mini-mental state examination (n = 3).
(18%), adverse drug reactions (17%), clinically problematic interactions (17%), renal insufficiency
(9%) and potentially inappropriate medication or dose for the elderly (9%, Fig. 1). Every patient in the
KUH group had drug-related, non-acute problems (Table 2). There were 293 non-acute DRPs (3.9 per
patient), which were typically related to reconsidering the need or efficacy of the medication (23%),
adverse drug reactions (15%) and monitoring (14%, Fig. 2).
4. Discussion
The accurate medication history recording and the medication chart is the basis for safe pharma-
cotherapy and a starting point for medication reviews. We found that the current process of medication
reconciliation at the admission of older ED patients in Finland is not adequate. Indeed, there was
only one patient of the KUH group whose admission medication chart was accurate and none of the
HUS group’s medication were accurate. Incorrect medication history recorded at admission leads to
prescription errors [4] and may complicate the identification of the correct admission diagnosis [21].
In general, adequate resources (time and staff) are not allocated for the recording of the medication his-
tory process, which includes medication reconciliation and review. Moreover, responsibilities between
health care professionals have not been explicitly demarked or agreed upon. Clinical pharmacists are
not widely assigned for recording medication history and the medication reconciliation processes in
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Fig. 2. The clinically relevant drug-related problems (DRPs, n = 447) obtained from 75 medication reviews in KUH.
∗Monitoring: checking laboratory results (n = 35), orthostatic measurement (n = 9), bone mass measurement (n = 4), ther-
apeutic drug monitoring (n = 2).
Finland even though there is evidence on benefits of their involvement from other countries with more
advanced clinical pharmacy practices [6, 22].
Our study showed that it is possible to prospectively identify and solve clinically relevant drug-
related problems of elderly ED patients with a pharmacists-led medication review. The used medication
review procedure is applicable to acute care settings, because it does not impede or slow down the
ED admission or the processing times. We have no exact data of the time spent per patient in the ED
admission process, but the process was designed not to prolong the treatment time of the patients. The
medication reconciliation process took approximately 10–30 minutes per patient, whereas medication
reviews usually take 1–2 hours per patient. It should be noted that using the knowledge of clinical
pharmacists at this level will save time in the long-run because it allows more time for the nurses and
physicians to concentrate on treating the patient. Earlier studies have shown that 10−30% of hospital
stays for older patients are drug-related [23, 24]. In the present study 16% of HUS patients and 29% of
KUH patients had drug-related problems that were certainly or probably linked to admissions (Table 2).
In addition, acute drug-related problems that required actions at ED were identified for 19% of HUS
patients and 72% of KUH patients. As much as 89% in HUS and every patient in KUH had drug-related,
non-acute problems, which should be resolved later after ED discharge. This reveals that medications
reviews should also be conducted on older patients with polypharmacy in non-acute settings.
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Table 4
Other than high-alert medications associated with admission diagnoses (HUS: n = 4, KUH: n = 15)
Unit Admission diagnoses Medications Medication Group
HUS fever, diarrhoea lymecycline + calcium +
magnesium
Antibiotics, Minerals
HUS stomach pain, high CRP etoricoxib + low dose ASA (no
proton pump inhibitors)
Antithrombotics, NSAIDS






HUS dizziness, nausea bisoprolol (patient experience,
temporal relationship)
Antihypertensives
KUH diarrhoea several antibiotic regimens Antibiotics
KUH atrial fibrillation metoprolol (non-adherence) Antiarrythmic agents,
Antihypertensives
KUH high low blood pressure amlodipine switched to valsartan
two weeks ago (due to swollen
ankles)
Antihypertensives





KUH collapse furosemide + telmisartan +
bisoprolol (+ low blood pressure)
Antihypertensives
KUH fall, urinary tract infection,
hyperkalemia
losartan (hyperkalemia)




KUH fall valsartan + hydrochlorothiazide
+ furosemide + spironolactone
(+ low blood pressure and
dehydration)
Antihypertensives, Diuretics
KUH fall amlodipine + bisoprolol +
ramipril
Antihypertensives









KUH fall, weakened general condition lisinopril + hydrochlorothiazide
+ metoprolol + simvastatin
Antihypertensives, Diuretics,
Statins
KUH weakened general condition furosemide (+ renal insufficiency
+ dose increased lately)
Diuretics
KUH cholecystitis Dida® Herbal Supplement
KUH arrhythmia, nausea, heartburns digoxin (+ renal insufficiency) Inotropic medications
KUH atrial fibrillation isosorbide mononitrate Nitrates
KUH diverticulitis, constipation leg
muscle cramps
atorvastatin Statins
ASA = acetylsalicylic acid.
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The clinical pharmacists were able to identify the patients with clinically relevant drug-related prob-
lems by using the agreed criteria. Hence, there is no urgent need for a referral for a medication review
by a physician or nurse. All the reported drug-related problems were accepted by the study supervising
physicians and are thus, clinically relevant. The clinical pharmacists were able to perform an effective
medication review after only a short training. Earlier studies show that medication reviews reduce ED
visits and an inpatient medication review conducted by pharmacists in close contact with physicians
might lead to fewer admissions and lower morbidity [25, 26]. An inpatient clinical pharmacist service
in the ED setting may also improve the safety of prescribing drugs and the patients’ health-related
quality of life [27]. After this study, HUS increased the clinical pharmacy services in its ED from a half-
day to a full-day (office hours) and the additional time is now allocated to medication reconciliation
and medication reviews for the patients with polypharmacy, high alert medications, renal insufficiency
and/or continuing ED visits. Medication reviews have been conducted by the clinical pharmacist in
the ED of KUH on a weekly basis before and after this study.
The results of medication reconciliations were similar, but results of the medication reviews showed
some differences between HUS and KUH groups. These disparities between the two centres can be
explained by the differences in the patient characteristics and the method of operation between the two
ED units. Patients are admitted at HUS tertiary ED only by referral or are taken there by ambulance. The
findings for HUS were, therefore, characteristic of a more severe setting (e.g. more severe admission
diagnoses and more high-alert medications related to admissions; Table 3) and there were more drug-
related problems per patient than that found for the KUH group (Table 2). Moreover, there were also
primary care patients in the secondary/primary ED of KUH whom had come directly from home with
several admission diagnoses of symptoms and signs e.g. dizziness, weakened general condition and
falls (Tables 3 and 4) and the patients at KUH were slightly older and used more medications (Table 1)
than their HUS counterparts. Although the findings at KUH were less severe compared to HUS, they
are not less important. If these drug-related problems are not resolved, the patients will burden the
health care system with repeated visits and readmissions.
High-alert medications in many countries, including Finland, are not officially defined. This study
provides additional information about high-alert medications of older ED patients at the admission
stage. The drug-related problems identified in the medication reviews accumulated for certain specific
medications, which enabled the identification of unit specific high-alert medications. High-alert med-
ications listed in the ISMP were involved in the admission of eight patients (11%) in HUS and six
patients (8%) in the KUH group (Table 3) [10, 11]. These included antithrombotics, cytostatics, opi-
oids and oral hypoglycaemic agents. The antithrombotics and cytostatics were also the leading causes
of drug-related inadvertent deaths in HUS in 2000 and in 2012 [28]. Regarding the non-high-alert
medications, antihypertensives and diuretics were commonly related to admission diagnoses in this
study (Table 3). When drug-related visits to a HUS district hospital ED were studied in 2001−2002,
antibiotics, cardiovascular drugs and non-steroidal anti-inflammatory drugs (NSAIDs) were the leading
causes for adverse drug reactions [29].
4.1. Study limitations
This study focused only on Finnish, home-dwelling older (≥65 year-old) ED patients, which might
be regarded as a limitation. The aim of this study, however, was to demonstrate the need for enhancing
the recording of medication history at admission of older ED patients in Finland. Patients receiving
home-care were excluded, because their medication charts were considered to be under better control.
According to a recent Finnish study, the majority of the home care clients had discrepancies between
in-home interview data and electronic medical records, and 40% of these discrepancies were clinically
important [30]. Hence, home care patients might also benefit from medication reconciliation and
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medication reviews. The differences between the findings of the medication reviews conducted in
HUS and KUH can be explained by the differences in the patient details and in the respective ED unit
procedures. Medication reviews were conducted in HUS and KUH by different teams, which may have
affected the findings. The clinical pharmacist of KUH introduced the clinical pharmacist of HUS to
the medication review procedure before the study commenced in order to harmonize the medication
reviews and minimize the risk of discrepancy due to differences in procedures. The teams had several
meetings during the study and the analyses of these data were made in close collaboration with the
study personnel of both centres.
5. Conclusions
A significant number of hospital stays for older patients are drug-related. This study showed that
the ED medication history taking procedure including reconciliation and review must be developed
further not only in primary and secondary hospital EDs but also in tertiary hospital EDs in Finland.
Trained clinical pharmacists were able to choose the patients and perform medication reviews, with-
out disturbing or impeding the normal ED routines and thus, allowed the nurses and physicians to
concentrate on the assessment and treatment of the patient. Furthermore, the drug-related problems
identified with regard to medication reviews accumulated for specific medications. Medication reviews
help to identify the high-alert medications at the ED admission stage and facilitate the compilation of
a specific high-alert medication list relevant to the emergency admission stage. Such lists should be
created in every ED setting.
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